Urethane-induced Mammary Carcinogenesis Susceptibility in Transgenic Mice Expressing a Dominant-negative TGF-β Type II Receptor

Anticancer Res. 2020 May;40(5):2687-2694. doi: 10.21873/anticanres.14239.

Abstract

Background/aim: Transforming growth factor-β (TGF-β) plays dual suppressive and oncogenic roles in mammary carcinogenesis.

Materials and methods: To analyze whether TGF-β exerts suppressive or oncogenic actions on mammary carcinogenesis, transgenic mice overexpressing a dominant-negative mutant type II TGF-β receptor (TβRII-DNR) driven by the mouse mammary tumor virus (MMTV) promoter were treated with a low dose of urethane, a carcinogen present in fermented food products and alcoholic beverages.

Results: Lobular proliferative lesions, showing high β-casein expression, developed in the mammary glands of TβRII-DNR+/+ mice aged >61 weeks. Compared with wild-type mice, TβRII-DNR+/+ mice administered with urethane showed significant increases in dysplastic hyperplasias and adenocarcinomas of the mammary glands.

Conclusion: The functional decline of TGF-β signaling in mammary glands led to a high susceptibility to urethane-induced mammary carcinogenesis. TGF-β signaling may act as a tumor suppressor during mammary tumor development.

Keywords: TGFβ signaling; environmental carcinogen; functional loss; mammary cancer.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Carcinogenesis / pathology*
  • Cell Proliferation / drug effects
  • Female
  • Genes, Dominant*
  • Lung Neoplasms / pathology
  • Mammary Glands, Animal / pathology
  • Mammary Neoplasms, Animal / chemically induced
  • Mammary Neoplasms, Animal / genetics*
  • Mammary Neoplasms, Animal / pathology
  • Mice, Transgenic
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptor, Transforming Growth Factor-beta Type II
  • Transgenes
  • Urethane

Substances

  • RNA, Messenger
  • Urethane
  • Receptor, Transforming Growth Factor-beta Type II